Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000232050 is a pseudogene found in Homo sapiens, described as similar to part of the ubiquitin-conjugating enzyme E2U (UBE2U). Pseudogenes are segments of DNA that resemble functional genes but typically carry mutations that prevent them from being expressed as proteins and do not have known biological activity. Because this entry is not transcribed into a functional protein, it has no recognized cellular or disease role, is not targeted by drugs, and is not considered a therapeutic or diagnostic target. Its reference to ubiquitin-conjugating enzyme E2U is due to sequence similarity, not function. Ubiquitin-conjugating enzymes (E2s, such as UBE2U) are enzymes involved in protein ubiquitination for degradation, but this pseudogene does not encode a functional E2 enzyme. Pseudogenes like ENSG00000232050 may occur throughout the genome but generally lack therapeutic or diagnostic significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of ubiquitin-conjugating enzyme E2U.